Recently, at the University of Pennsylvania, an adenovirus-induced CAR-M composed of an anti-HER2 CAR and the CD3ζ intracellular domain was designed, demonstrating in vitro its specificity in terms of antigen-specific phagocytosis against HER2-positive tumor cells. Here, CD247 is linked to neoplasm.